1
项与 CD147- CAR T cells(Peking University People's Hospital) 相关的临床试验 / Not yet recruiting早期临床1期IIT A Pioneering Study on the Safety and Efficacy of CD147-Chimeric Antigen Receptor (CAR) T Cells in Patients With Relapsed or Refractory T-cell Non-Hodgkin's Lymphoma
The safety and preliminary effectiveness of CD147-CAR T cells in patients with relapsed or refractory T cell non-Hodgkin's lymphoma will be investigated in this pioneering study.
100 项与 CD147- CAR T cells(Peking University People's Hospital) 相关的临床结果
100 项与 CD147- CAR T cells(Peking University People's Hospital) 相关的转化医学
100 项与 CD147- CAR T cells(Peking University People's Hospital) 相关的专利（医药）
100 项与 CD147- CAR T cells(Peking University People's Hospital) 相关的药物交易
